​
​

Ginkgo Bioworks (DNA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Ginkgo Bioworks Revenue Highlights

Latest Revenue (Y)

$251.46M

Latest Revenue (Q)

$89.05M

Main Segment (Y)

Service

Ginkgo Bioworks Revenue by Period

Ginkgo Bioworks Revenue by Year

DateRevenueChange
2023-12-31$251.46M-47.36%
2022-12-31$477.71M52.21%
2021-12-31$313.84M309.40%
2020-12-31$76.66M41.48%
2019-12-31$54.18M-44.87%
2001-12-31$98.28M-

Ginkgo Bioworks generated $251.46M in revenue during NA 2023, up -47.36% compared to the previous quarter, and up 255.84% compared to the same period a year ago.

Ginkgo Bioworks Revenue by Quarter

DateRevenueChange
2024-09-30$89.05M58.43%
2024-06-30$56.21M48.13%
2024-03-31$37.94M9.18%
2023-12-31$34.76M-37.30%
2023-09-30$55.43M-31.20%
2023-06-30$80.57M-0.17%
2023-03-31$80.70M-17.89%
2022-12-31$98.28M48.02%
2022-09-30$66.40M-54.09%
2022-06-30$144.62M-14.12%
2022-03-31$168.41M13.41%
2021-12-31$148.49M91.33%
2021-09-30$77.61M77.86%
2021-06-30$43.64M-1.05%
2021-03-31$44.10M37.55%
2020-12-31$32.06M141.00%
2020-09-30$13.30M30.89%
2020-06-30$10.16M-51.91%
2020-03-31$21.13M-68.17%
2001-09-30$66.40M-54.09%
2001-06-30$144.62M-14.12%
2001-03-31$168.41M-

Ginkgo Bioworks generated $89.05M in revenue during Q3 2024, up 58.43% compared to the previous quarter, and up 110.52% compared to the same period a year ago.

Ginkgo Bioworks Revenue Breakdown

Ginkgo Bioworks Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
Service$78.97M$298.58M$177.81M
Product$28.95M$35.45M$23.04M
Foundry Revenue-$143.67M$112.99M

Ginkgo Bioworks's latest annual revenue breakdown by segment (product or service), as of Dec 23: Service (73.18%), and Product (26.82%).

Quarterly Revenue by Product

Product/ServiceSep 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21
Service$13.96M$19.54M$24.50M$34.94M$32.60M$36.53M$96.49M$132.97M$105.92M$34.38M
Product-$6.50M$10.79M$11.67M$12.43M$5.19M$3.89M$13.95M$8.42M$8.49M
Foundry Revenue----$53.26M$24.68M$44.24M$21.49M--

Ginkgo Bioworks's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Service (100.00%).

Ginkgo Bioworks Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
DNAGinkgo Bioworks$251.46M$89.05M
CWBRCohBar--
AVROAVROBIO--
ELEVElevation Oncology--
OCEAOcean Biomedical--
HEPAHepion Pharmaceuticals--
ENVBEnveric Biosciences--

DNA Revenue FAQ

What is Ginkgo Bioworks’s yearly revenue?

Ginkgo Bioworks's yearly revenue for 2023 was $251.46M, representing a decrease of -47.36% compared to 2022. The company's yearly revenue for 2022 was $477.71M, representing an increase of 52.21% compared to 2021. DNA's yearly revenue for 2021 was $313.84M, representing an increase of 309.40% compared to 2020.

What is Ginkgo Bioworks’s quarterly revenue?

Ginkgo Bioworks's quarterly revenue for Q3 2024 was $89.05M, a 58.43% increase from the previous quarter (Q2 2024), and a 60.65% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $56.21M, a 48.13% increase from the previous quarter (Q1 2024), and a -30.24% decrease year-over-year (Q2 2023). DNA's quarterly revenue for Q1 2024 was $37.94M, a 9.18% increase from the previous quarter (Q4 2023), and a -52.98% decrease year-over-year (Q1 2023).

What is Ginkgo Bioworks’s revenue growth rate?

Ginkgo Bioworks's revenue growth rate for the last 3 years (2021-2023) was -19.88%, and for the last 5 years (2019-2023) was 364.08%.

What are Ginkgo Bioworks’s revenue streams?

Ginkgo Bioworks's revenue streams in c 23 are Service, and Product. Service generated $78.98M in revenue, accounting 73.18% of the company's total revenue, down -73.55% year-over-year. Product generated $28.95M in revenue, accounting 26.82% of the company's total revenue, down -18.35% year-over-year.

What is Ginkgo Bioworks’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Ginkgo Bioworks was Service. This segment made a revenue of $78.98M, representing 73.18% of the company's total revenue.